NYSE: IQV
IQVIA Holdings Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$28.00B
52w High
$247.05
52w Low
$153.01
P/E
20.57
Volume
3.67M
Outstanding Shares
166.90M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 8.51% over the last year. Revenue grew 7.32% over the trailing twelve months. Operating margin moved from 14.33% to 13.86%. Free cash flow grew 17.66% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 13.86%. A decisive move in revenue — currently up 7.32% — would be the clearest signal to resolve the ambiguity.
Company profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
36
Buy
7
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 28, 2026
Q3 FY26 · EPS est $3.03 · Revenue est $4.31B
View